COX‐2 inhibitors suppress integrin α5 expression in human lung carcinoma cells through activation of Erk: Involvement of Sp1 and AP‐1 sites

ShouWei Han, Jesse Roman

Open source

DOI
10.1002/ijc.21125
Published
2005-04-11
Container
International Journal of Cancer
Publisher
Wiley
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijc.21125,
  title = {COX‐2 inhibitors suppress integrin α5 expression in human lung carcinoma cells through activation of Erk: Involvement of Sp1 and AP‐1 sites},
  author = {ShouWei Han and Jesse Roman},
  year = {2005},
  journal = {International Journal of Cancer},
  doi = {10.1002/ijc.21125},
  url = {https://doi.org/10.1002/ijc.21125}
}

RIS

TY  - JOUR
TI  - COX‐2 inhibitors suppress integrin α5 expression in human lung carcinoma cells through activation of Erk: Involvement of Sp1 and AP‐1 sites
AU  - ShouWei Han
AU  - Jesse Roman
PY  - 2005
JO  - International Journal of Cancer
DO  - 10.1002/ijc.21125
UR  - https://doi.org/10.1002/ijc.21125
ER  - 

APA

Han, S., & Roman, J. (2005). COX‐2 inhibitors suppress integrin α5 expression in human lung carcinoma cells through activation of Erk: Involvement of Sp1 and AP‐1 sites. International Journal of Cancer. https://doi.org/10.1002/ijc.21125

Source records